BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34090509)

  • 21. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.
    He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C
    Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.
    Drooger J; Akdeniz D; Pignol JP; Koppert LB; McCool D; Seynaeve CM; Hooning MJ; Jager A
    Breast Cancer Res Treat; 2015 Nov; 154(1):171-80. PubMed ID: 26467044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
    Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term monitoring of cell-mediated immunity in disease-free breast cancer patients: a preliminary retrospective study.
    Nicolini A; Carpi A; Ferrari P; Tartarelli G; Anselmi L; Metelli MR; Gorini I; Spinelli C; Miccoli P; Giardino R
    Biomed Pharmacother; 2002 Sep; 56(7):339-44. PubMed ID: 12418581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated flow cytometry enables high performance point-of-care analysis of leukocyte phenotypes.
    Spijkerman R; Hesselink L; Hellebrekers P; Vrisekoop N; Hietbrink F; Leenen LPH; Koenderman L
    J Immunol Methods; 2019 Nov; 474():112646. PubMed ID: 31419409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression.
    Wang Y; Zhou N; Zhu R; Li X; Sun Z; Gao Y; Liu W; Meng C; Ge Y; Bai C; Li T; Liu H
    BMC Pulm Med; 2021 Sep; 21(1):282. PubMed ID: 34488711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
    Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
    Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential binding of heparin to granulocytes of various species.
    Harenberg J; Malsch R; Piazolo L; Huhle G; Heene DL
    Am J Vet Res; 1996 Jul; 57(7):1016-20. PubMed ID: 8807013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased circulating M2-like monocytes in patients with breast cancer.
    Zhang B; Cao M; He Y; Liu Y; Zhang G; Yang C; Du Y; Xu J; Hu J; Gao F
    Tumour Biol; 2017 Jun; 39(6):1010428317711571. PubMed ID: 28639912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smoking reduces circulating CD26
    Ammitzbøll C; Börnsen L; Romme Christensen J; Ratzer R; Romme Nielsen B; Søndergaard HB; von Essen MR; Sellebjerg F
    J Leukoc Biol; 2017 May; 101(5):1211-1220. PubMed ID: 28179539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer.
    Muraro E; Furlan C; Avanzo M; Martorelli D; Comaro E; Rizzo A; Fae' DA; Berretta M; Militello L; Del Conte A; Spazzapan S; Dolcetti R; Trovo' M
    Front Immunol; 2017; 8():1476. PubMed ID: 29163540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
    Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
    Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes.
    Wang L; Simons DL; Lu X; Tu TY; Avalos C; Chang AY; Dirbas FM; Yim JH; Waisman J; Lee PP
    EBioMedicine; 2020 Feb; 52():102631. PubMed ID: 31981982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of breast cancer after Hodgkin's lymphoma and paediatric cancer.
    Terenziani M; Massimino M; Magazzù D; Gandola L; Capri G; Carcangiu ML; Catania S; Di Russo A; Gennaro M; Meazza C; Podda M; Schiavello E; Valagussa P
    Eur J Cancer; 2015 Sep; 51(13):1667-74. PubMed ID: 26092639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerations.
    Hehr T; Baumann R; Budach W; Duma MN; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Krug D; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R;
    Strahlenther Onkol; 2019 Nov; 195(11):949-963. PubMed ID: 31451835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous detection of circulating immunological parameters and tumor biomarkers in early stage breast cancer patients during adjuvant chemotherapy.
    Rovati B; Mariucci S; Delfanti S; Grasso D; Tinelli C; Torre C; De Amici M; Pedrazzoli P
    Cell Oncol (Dordr); 2016 Jun; 39(3):211-28. PubMed ID: 26769126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of irinotecan on the phenotype of peripheral blood leukocyte populations in patients with metastatic colorectal cancer.
    Melichar B; Touskova M; Vesely P
    Hepatogastroenterology; 2002; 49(46):967-70. PubMed ID: 12143255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study.
    Cimino-Mathews A; Ye X; Meeker A; Argani P; Emens LA
    Hum Pathol; 2013 Oct; 44(10):2055-63. PubMed ID: 23701942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.